Find what you’re looking for

October 27, 2020 | News

ANGLE raises £20M on London Stock Exchange

ANGLE raises £20M on London Stock Exchange

Surrey Research Park tenant, ANGLE, a liquid biopsy company that develops products for use in rare cell diagnostics, has raised gross proceeds of £20m through a conditional placing on the London Stock Exchange.

ANGLE focuses on early diagnoses for the prevention, treatment and monitoring of diseases.

The placing comprises 43.4 million shares at a price of 46p each.

ANGLE will use the funding for its metastatic breast cancer and ovarian cancer products, establishing clinical laboratories for pharma services, assay development and commercial expansion.

Our response toCOVID-19 >